Myunghee Lee
Physician Assistant · Durham, NCNPI 1942914510
Payments from drug & device makers
Across 93 payments — averaging $19.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$555
- Dexcom, Inc.$167
- Mannkind Corporation$151
- Radius Health, Inc.$106
- Amgen$93
- Bayer$93
- plus $660 from 17 others
What the payments were for
- Food & beverage$1,77697%
- Education$503%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 33 | $555 |
| Dexcom, Inc. | 8 | $167 |
| Mannkind Corporation | 8 | $151 |
| Radius Health, Inc. | 4 | $106 |
| Amgen | 6 | $93 |
| Bayer | 4 | $93 |
| Xeris Pharmaceuticals, Inc. | 4 | $91 |
| Recordati_rare_diseases_inc. | 3 | $73 |
| Currax Pharmaceuticals LLC | 3 | $65 |
| Novo Nordisk | 2 | $62 |
| Boehringer Ingelheim | 2 | $52 |
| Insulet Corporation | 2 | $43 |
| Halozyme Inc | 2 | $36 |
| AstraZeneca | 2 | $34 |
| Almatica Pharma LLC | 1 | $29 |
| Antares Pharma, Inc. | 2 | $29 |
| Ascendis Pharma Endocrinology Inc | 1 | $25 |
| Medtronic | 1 | $24 |
| Kyowa Kirin, Inc. | 1 | $24 |
| Verity Pharmaceuticals Inc. | 1 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Amryt Pharma Holdings Ltd | 1 | $17 |
| Corcept Therapeutics | 1 | $17 |
How this compares
$1,826 in reported general payments places this provider in the 80th percentile of 7,441 physician assistant providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 727 | $901,326 |
| TrulicityDulaglutide | 508 | $666,936 |
| JardianceEmpagliflozin | 511 | $501,226 |
| RybelsusSemaglutide | 132 | $202,939 |
| MounjaroTirzepatide | 167 | $191,005 |
| FarxigaDapagliflozin Propanediol | 162 | $190,626 |
| JanuviaSitagliptin Phosphate | 69 | $63,461 |
| ProliaDenosumab | 26 | $43,713 |
| Teriparatide | 13 | $37,343 |
| Cinacalcet Hcl | 79 | $35,989 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 97 | $35,098 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 33 | $33,546 |
| V-Go 30Sub-Q Insulin Device, 30 Unit | 57 | $32,486 |
| V-Go 20Sub-Q Insulin Device, 20 Unit | 50 | $29,699 |
| Humalog Kwikpen U-100Insulin Lispro | 140 | $29,287 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus, Fiasp, Novolog | $62 | $1,134,306942 claims |
| Lilly USA, LLCTrulicity, Mounjaro, Humalog | $555 | $871,865754 claims |
| Boehringer IngelheimJardiance, Tradjenta | $52 | $508,965524 claims |
| AstraZenecaFarxiga | $34 | $190,626162 claims |
| AmgenProlia | $93 | $43,71326 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33, Lantus | $18 | $24,43483 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 7,441 physician assistant providers in North Carolina.
Other physician assistant in Durham
- Joseph LicataDurham$29K
- Beth ParenteDurham$28K
- Jo HughesGreensboro$814K
- Rachel HolzhauerCharlotte$739K
- Amber BlairCharlotte$551K
- Benjamin EpsteinDavidson$447K
- Rebecca KrausDavidson$425K
- Brooke JonesGoldsboro$259K
- Philip ReasbeckWilson$180K
- Katherine SchultzHuntersville$164K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.